Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Nuon Therapeutics, Inc.
The primary objective of this study is to assess the efficacy and safety of two different doses of tranilast as determined by ACR20 response at 12 weeks.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Receiving methotrexate
Have at least 8 painful/tender and 6 swollen joints
May be receiving oral steroids, chronic NSAIDs and/or hydroxychloroquine.
Pregnant or nursing females
Abnormal laboratory values
History of clinically significant renal, hepatic dysfunction, psychiatric disorder, or alcohol/drug dependence
